For the interim period of the fiscal year ending February 2027, revenue was 79,733 million yen (YoY +21.5%), operating income was 23,096 million yen (+42.4%), ordinary income was 24,538 million yen (+68.4%), and interim net income attributable to owners of parent was 15,839 million yen (+45.7%), all increasing. The company disclosed revisions to its full-year earnings guidance and revised its dividend forecast. Segment performance was strong in semiconductor and FPD-related equipment, while life sciences experienced a slight sales decline. Financial position improved, including an increase in cash and deposits.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6323","jir_company_name":"Rorze Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-08","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/6323-20261008-01.pdf","jir_short_summary":"For the interim period of the fiscal year ending February 2027, revenue was 79,733 million yen (YoY +21.5%), operating income was 23,096 million yen (+42.4%), ordinary income was 24,538 million yen (+68.4%), and interim net income attributable to owners of parent was 15,839 million yen (+45.7%), all increasing. The company disclosed revisions to its full-year earnings guidance and revised its dividend forecast. Segment performance was strong in semiconductor and FPD-related equipment, while life sciences experienced a slight sales decline. Financial position improved, including an increase in cash and deposits.","jir_summary":"### Performance Highlights\nRorze Corporation achieved significant profit growth in the interim period of the fiscal year ending February 2027, recording revenue of 79,733 million yen, operating income of 23,096 million yen, and ordinary income of 24,538 million yen. By segment, solid performance in the semiconductor and FPD-related equipment business contributed to results, while the life sciences segment expanded sales but recorded a loss. The increase in cash and deposits has also strengthened the financial position.\n\n### Outlook and Dividends\nThe company has revised its full-year earnings guidance for the fiscal year ending February 2027 and updated its dividend forecast. Exchange rate effects and medium-term demand trends may influence future indicators, so continued monitoring of these trends is necessary.","jir_financial_highlights":"Revenue: 79,733 million yen (Year-over-Year 23.1% increase (Note: body states 21.5% increase))\nOperating Income: 23,096 million yen (Year-over-Year 42.4% increase)\nOrdinary Income: 24,538 million yen (Year-over-Year 68.4% increase)\nNet Income Attributable to Owners of Parent (Interim): 15,839 million yen (Year-over-Year 45.7% increase)\nEarnings per Share (Interim): 91.33 yen (Previous 62.13 yen \u2192 Current 91.33 yen (after dilution))\nEquity Ratio: 67.2% (Previous 66.0% \u2192 Current 67.2%)","jir_category":"","jir_hashtags":"#RorzeCorporation, #Earnings, #InterimResults","jir_key_figures":"Revenue: 79,733 million yen\nOperating Income: 23,096 million yen\nInterim Net Income: 15,839 million yen","jir_meta_title":"Rorze Corporation Second Quarter Financial Summary for Fiscal Year Ending February 2027 | Key Metrics & Outlook","jir_meta_description":"Rorze Corporation's second quarter financial summary for the fiscal year ending February 2027. Summary of revenue and profit trends, segment performance, financial position, and revisions to full-year forecasts for investors.","jir_og_title":"Rorze Corporation Interim Financial Results Overview for Fiscal Year Ending February 2027","jir_og_description":"Rorze Corporation interim results: revenue 79,733 million yen, operating income 23,096 million yen. Includes revisions to full-year outlook and updated dividend forecast.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026\/2\\\",\\\"2026\/8\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[75602,79733]}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026\/2\\\",\\\"2026\/8\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[16214,23096]}]}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Interim Net Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026\/2\\\",\\\"2026\/8\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Interim Net Income\\\",\\\"data\\\":[10872,15839]}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Semiconductor & FPD-related Equipment\\\",\\\"Life Sciences\\\"],\\\"datasets\\\":[{\\\"data\\\":[79333-404?],\\\"label\\\":\\\"Revenue\\\"}]}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Margin Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Interim\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin\\\",\\\"data\\\":[29.2]}]}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Comparison of Forecasts and Actuals\", \"jir_chart_json_data\": \"{\\\"headers\\\":[\\\"Item\\\",\\\"Actual\\\",\\\"Forecast\\\"],\\\"rows\\\":[[\\\"Revenue\\\",\\\"79,733\\\",\\\"180,007\\\"],[\\\"Operating Income\\\",\\\"23,096\\\",\\\"53,078\\\"]]}\"}]","ir_related_company":8056,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-128513","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n